PEGS 2021: Isogenica presents latest VHH data
Isogenica is excited to announce its corporate sponsorship at PEGS November 2-4th 2021
Isogenica is delighted to announce its attendance at PEGS Europe 2021 as Corporate Sponsors, were members of the Isogenica Team will be attending in person at Barcelona.
Isogenica’s Senior Scientist of Assay Development, Lurdes Duarte, will be hosting a presentation on the latest data on Isogenica’s VHH as next generation therapeutics.
Join Lurdes on Wednesday 3rd November at 12:40 CET
Alternatively, you can engage with the rest of the Isogenica Team at our poster presentation both virtually and in-person.
If Isogenica VHH antibodies have application in your discovery projects or you would like to learn more about partnering with Isogenica, get in touch and we will be glad to schedule a meeting.
Isogenica has developed LlamdA™ (single domain VHH) therapeutic antibodies from its proprietary fully synthetic antibody libraries and leveraging its CIS Display and Colibra™ technologies to accelerate the discovery and development process. Over the last four years Isogenica has entered into eight significant partnerships, leveraging its libraries, technologies and expertise to build a broad pipeline of programs that are now advancing into pre-clinical and early clinical development with our partners.”
T +44 1799 533 680